UBS Group reissued their neutral rating on shares of Smith & Nephew (LON:SN) in a research note published on Thursday, investing.thisismoney.co.uk reports.
SN has been the subject of a number of other research reports. Credit Suisse Group upped their price objective on shares of Smith & Nephew from GBX 1,330 ($17.38) to GBX 1,390 ($18.16) and gave the company a neutral rating in a research note on Friday, February 8th. Deutsche Bank raised shares of Smith & Nephew to a hold rating and upped their price objective for the company from GBX 1,200 ($15.68) to GBX 1,350 ($17.64) in a research note on Monday, December 10th. JPMorgan Chase & Co. upped their price objective on shares of Smith & Nephew from GBX 1,477 ($19.30) to GBX 1,516 ($19.81) and gave the company a neutral rating in a research note on Monday, February 11th. BNP Paribas cut shares of Smith & Nephew to a neutral rating and upped their price objective for the company from GBX 1,475 ($19.27) to GBX 1,525 ($19.93) in a research note on Friday, February 8th. Finally, Goldman Sachs Group upped their price objective on shares of Smith & Nephew from GBX 1,400 ($18.29) to GBX 1,440 ($18.82) and gave the company a neutral rating in a research note on Monday, February 11th. Nine analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus target price of GBX 1,479.36 ($19.33).
Shares of Smith & Nephew stock opened at GBX 1,480 ($19.34) on Thursday. Smith & Nephew has a 52-week low of GBX 1,242.50 ($16.24) and a 52-week high of GBX 1,548.50 ($20.23). The firm has a market capitalization of $12.94 billion and a PE ratio of 19.55. The company has a debt-to-equity ratio of 30.12, a current ratio of 2.10 and a quick ratio of 1.08.
The company also recently declared a dividend, which will be paid on Wednesday, May 8th. Shareholders of record on Thursday, April 4th will be given a dividend of $0.22 per share. The ex-dividend date is Thursday, April 4th. This represents a yield of 1.1%. This is a boost from Smith & Nephew’s previous dividend of $0.14. Smith & Nephew’s dividend payout ratio is presently 0.37%.
In other Smith & Nephew news, insider Susan Swabey sold 1,097 shares of the stock in a transaction on Thursday, March 7th. The shares were sold at an average price of GBX 1,453 ($18.99), for a total transaction of £15,939.41 ($20,827.66).
Smith & Nephew Company Profile
Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Featured Article: Short Selling Stocks, A Beginner’s Guide
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.